CompaniesRhone-Poulenc Rorer

Rhone-Poulenc Rorer

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

2

As Collaborator

4

Total Enrollment

292

By Phase

PHASE2: 3NA: 2PHASE1: 1

By Status

COMPLETED: 6
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT00148070
NCT00321009
NCT01928576
Hover over trial bars to see details

Recent Trials

NCT01928576Collaborator
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.
PHASE2Completed
143 participants
Started: Nov 6, 2013 · Completed: Apr 4, 2023
NCT00321009Collaborator
LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
NACompleted
60 participants
Started: Mar 31, 2000 · Completed: Apr 30, 2004
NCT00005096Collaborator
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
PHASE2Completed
19 participants
Started: Dec 31, 1999 · Completed: Jun 30, 2002
NCT00148070Collaborator
Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
PHASE2Completed
45 participants
Started: Mar 31, 1999 · Completed: Feb 28, 2006
NCT00000980Lead Sponsor
A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea
PHASE1Completed
25 participants
View all 6 trials →
Related Companies
Hoechst Agto Form Aventis
merged